- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 16/22 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors
Patent holdings for IPC class C07K 16/22
Total number of patents in this class: 4306
10-year publication summary
|
375
|
327
|
342
|
339
|
409
|
351
|
342
|
314
|
293
|
207
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Regeneron Pharmaceuticals, Inc. | 4701 |
249 |
| Genentech, Inc. | 4104 |
156 |
| F. Hoffmann-La Roche AG | 7837 |
121 |
| Hoffmann-La Roche Inc. | 3793 |
118 |
| Novartis AG | 10262 |
91 |
| Scholar Rock, Inc. | 137 |
85 |
| Amgen Inc. | 4427 |
72 |
| Mayo Foundation for Medical Education and Research | 3382 |
56 |
| Zoetis Services LLC | 1547 |
46 |
| The Regents of the University of California | 20745 |
45 |
| Genzyme Corporation | 1368 |
44 |
| Chugai Seiyaku Kabushiki Kaisha | 1423 |
42 |
| Boehringer Ingelheim International GmbH | 4493 |
40 |
| Xencor, Inc. | 413 |
35 |
| Acceleron Pharma Inc. | 340 |
33 |
| Abbvie Inc. | 1836 |
27 |
| Pfizer Inc. | 3386 |
26 |
| Eli Lilly and Company | 4101 |
25 |
| REGENXBIO Inc. | 247 |
24 |
| Samsung Electronics Co., Ltd. | 157719 |
23 |
| Other owners | 2948 |